​

MediWound (MDWD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MDWD Stock Forecast

MediWound (MDWD) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $28.00 and a low of $28.00. This represents a 40.28% increase from the last price of $19.96.

$10 $14 $18 $22 $26 $30 High: $28 Avg: $28 Low: $28 Last Closed Price: $19.96

MDWD Stock Rating

MediWound stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

MDWD Forecast vs Benchmarks

TypeNameUpside
StockMediWound40.28%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$32.00
Last Closing Price$19.96$19.96$19.96
Upside/Downside--60.32%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2522---4
Dec, 2422---4
Nov, 2432---5
Oct, 2432---5
Sep, 2432---5
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 11, 2024Swayampakula RamakanthH.C. Wainwright$28.00$16.9265.48%40.28%
May 29, 2024Francois BriseboisOppenheimer$36.00$16.01124.86%80.36%
Jan 04, 2023H.C. Wainwright$23.00$13.2973.06%15.23%
Dec 30, 2022Cowen & Co.$25.00$13.4985.32%25.25%
Dec 22, 2022Maxim Group$25.00$11.01127.07%25.25%
Nov 16, 2022H.C. Wainwright$0.79$0.24229.17%-96.04%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 11, 2024H.C. WainwrightBuyBuyhold
Sep 17, 2024Cowen & Co.BuyBuyhold
Aug 05, 2024Cowen & Co.BuyBuyhold
May 29, 2024OppenheimerOutperformOutperformhold
Dec 30, 2022Cowen & Co.OutperformOutperformhold
Dec 22, 2022Maxim GroupBuyinitialise
Dec 21, 2022OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.47$-3.48$-3.93$-0.75-----
Avg Forecast$-2.73$-3.43$-2.02$-0.80$-3.32$-2.24$-1.44$-0.01$1.64
High Forecast$-2.81$-3.54$-2.17$-0.96$-3.45$-2.68$-1.87$-0.43$1.53
Low Forecast$-2.67$-3.36$-1.89$-0.53$-3.23$-1.83$-1.11$0.41$1.80
Surprise %-9.52%1.46%94.55%-6.25%-----

Revenue Forecast

$15M $35M $55M $75M $95M $115M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$21.76M$23.76M$26.50M$18.69M-----
Avg Forecast$20.68M$23.85M$21.53M$18.67M$20.18M$25.35M$31.58M$64.47M$102.83M
High Forecast$20.35M$23.47M$20.48M$17.95M$19.83M$24.00M$31.58M$64.47M$97.36M
Low Forecast$21.16M$24.41M$22.74M$19.12M$20.87M$27.22M$31.58M$64.47M$110.41M
Surprise %5.26%-0.37%23.04%0.11%-----

Net Income Forecast

$-35M $-24M $-13M $-2M $9M $20M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-9.60M$-13.55M$-19.60M$-6.72M-----
Avg Forecast$-11.44M$-30.94M$-12.54M$-6.72M$-30.08M$-22.96M$-15.95M$236.00K$14.78M
High Forecast$-13.73M$-31.88M$-15.05M$-8.06M$-31.07M$-24.19M$-16.85M$-3.83M$13.76M
Low Forecast$-9.15M$-30.30M$-10.03M$-5.37M$-29.09M$-16.46M$-10.00M$3.65M$16.20M
Surprise %-16.08%-56.20%56.29%------

MDWD Forecast FAQ

Is MediWound stock a buy?

MediWound stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MediWound is a favorable investment for most analysts.

What is MediWound's price target?

MediWound's price target, set by 4 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $28 at the low end to $28 at the high end, suggesting a potential 40.28% change from the previous close price of $19.96.

How does MediWound stock forecast compare to the average forecast of its sector, industry, and investment themes?

MediWound stock forecast shows a 40.28% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for MediWound over the past three months?

  • January 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 60.00% Strong Buy, 40.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is MediWound’s EPS forecast?

MediWound's average annual EPS forecast for its fiscal year ending in December is -3.32 for 2024, a 342.67% increase from the reported $-0.75 in 2023. The prediction for 2025 is $-2.24, $-1.44 for 2026, $-0.01 for 2027, and $1.64 for 2028.

What is MediWound’s revenue forecast?

MediWound's average annual revenue forecast for its fiscal year ending in December is $20.18M for 2024, a 8.02% increase from the reported $18.69M in 2023. The forecast for 2025 is $25.35M, $31.58M for 2026, $64.47M for 2027, and $102.83M for 2028.

What is MediWound’s net income forecast?

For its fiscal year ending in December, MediWound's average annual net income forecast is $-30.081M for 2024, reflecting an 347.90% increase from the reported $-6.716M in 2023. The projection for 2025 is $-22.956M, $-15.949M for 2026, $236K for 2027, and $14.78M for 2028.